[
  {
    "date": "2023-12-30",
    "symbol": "PBLA",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39468",
    "entityregistrantname": "PANBELA THERAPEUTICS, INC",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "88-2805017",
    "entityaddressaddressline1": "712 Vista Blvd, #305",
    "entityaddresscityortown": "Waconia",
    "entityaddressstateorprovince": "MN",
    "entityaddresspostalzipcode": 55387,
    "cityareacode": 952,
    "localphonenumber": "479-1196",
    "security12btitle": "Common Stock, $0.001 par value",
    "tradingsymbol": "PBLA",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entitysmallbusiness": "true",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 677,
    "auditorname": "Cherry Bekaert LLP",
    "auditorlocation": "Tampa, Florida",
    "entitycentralindexkey": 1029125,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false",
    "cashandcashequivalentsatcarryingvalue": 2578000,
    "prepaidexpenseandotherassetscurrent": 299000,
    "incometaxesreceivable": 183000,
    "assetscurrent": 3060000,
    "otherassetsnoncurrent": 8742000,
    "assets": 11802000,
    "accountspayablecurrent": 9939000,
    "accruedliabilitiescurrent": 1141000,
    "interestpayablecurrent": 238000,
    "otherlongtermdebtcurrent": 1000000,
    "liabilitiescurrent": 12318000,
    "longtermdebtnoncurrent": 4194000,
    "liabilitiesnoncurrent": 4194000,
    "liabilities": 16512000,
    "treasurystockcommonvalue": 1000,
    "additionalpaidincapital": 120043000,
    "retainedearningsaccumulateddeficit": -125497000,
    "accumulatedothercomprehensiveincomelossnetoftax": 745000,
    "stockholdersequity": -4710000,
    "liabilitiesandstockholdersequity": 11802000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 480095,
    "commonstocksharesoutstanding": 480025,
    "treasurystockcommonshares": 70,
    "generalandadministrativeexpense": 5033000,
    "researchanddevelopmentexpense": 20614000,
    "operatingincomeloss": -25647000,
    "investmentincomeinterest": 123000,
    "gainlossondispositionofintangibleassets": 400000,
    "interestexpense": 317000,
    "othernonoperatingincomeexpense": -8000,
    "nonoperatingincomeexpense": 198000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -25449000,
    "incometaxexpensebenefit": -186000,
    "netincomeloss": -25263000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -14000,
    "comprehensiveincomenetoftax": -25277000,
    "earningspersharebasic": -316.52,
    "weightedaveragenumberofsharesoutstandingbasic": 108691,
    "sharesoutstanding": 480328,
    "stockissuedduringperiodsharesnewissues": 124612,
    "stockissuedduringperiodvaluenewissues": 21456000,
    "stockissuedduringperiodsharesexerciseofwarrantsforcash": 330470,
    "stockissuedduringperiodvalueexerciseofwarrantsforcash": 4749000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 823000,
    "stockissuedduringperiodsharesreversestocksplits": -390,
    "adjustmentstoadditionalpaidincapitalreversestocksplit": -9000,
    "stockissuedduringperiodsharescashlessexerciseofwarrants": 22750,
    "commonstockrepurchasedfortreasurystock": -70,
    "treasurystockvalueacquiredcostmethod": 1000,
    "treasurystocksharesacquired": 70,
    "treasurystockvalueacquiredparmethod": 1000,
    "adjustmentstoadditionalpaidincapitaltoinducewarrantexercise": 9140000,
    "sharebasedcompensation": 823000,
    "amortizationofdebtdiscountpremium": 238000,
    "increasedecreaseinincometaxesreceivable": 132000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -145000,
    "increasedecreaseindepositotherassets": 5541000,
    "increasedecreaseinaccountspayable": 7060000,
    "increasedecreaseinaccruedliabilities": -2179000,
    "netcashprovidedbyusedinoperatingactivities": -25249000,
    "proceedsfromsaleofintangibleassets": 400000,
    "netcashprovidedbyusedininvestingactivities": 400000,
    "proceedsfromissuanceofcommonstocknet": 1597000,
    "proceedsfromissuanceorsaleofequitynet": 21456000,
    "proceedsfromwarrantexercises": 3526000,
    "repaymentsofnotespayable": 1650000,
    "paymentsforfractionalshares": 10000,
    "netcashprovidedbyusedinfinancingactivities": 26142000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 1293000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 2578000,
    "interestpaidnet": 404000,
    "noncashadjustmentforthevalueofferedtoinducewarrantsexercise": 9140,
    "paymentsofstockissuancecosts": 49000,
    "paymentsfrominducedexerciseofwarrants": 359000,
    "accumulatedlossfrominducedwarrantexercises": 9100000,
    "workingcapital": -9300000,
    "proceedsfromissuanceofcommonstock": 1600000,
    "cashuninsuredamount": 2300000,
    "warrantinducementcost": 9100000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 607,
    "clinicaltrialrelatedliabilitiescurrent": 290000,
    "accruedbonusescurrent": 420000,
    "accruedsupplementalunemploymentbenefitsseverancebenefitsandpayrolltaxescurrent": 96000,
    "accruedprofessionalfeescurrent": 166000,
    "otheraccruedliabilitiescurrent": 169000,
    "longtermdebt": 5400000,
    "interestpayablecurrentandnoncurrent": 238000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 9595,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 12.39,
    "researchexpenseremainingbalance": 375000,
    "classofwarrantsorrightseligibleforcashlessexercise": 2595,
    "classofwarrantorrightexercisedduringperiod": 25705,
    "commonstockcapitalsharesreservedforfutureissuance": 607,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 561,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 14420,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 607,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P0Y2M26D",
    "allocatedsharebasedcompensationexpense": 643000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 14410.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantsinperiod": 503,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 300,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 300,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 503,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P9Y2M26D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 78,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P9Y2M26D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 7709,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionscommonstockfairvalue": 300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0359,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.313,
    "deferredtaxassetsoperatinglosscarryforwards": 18487000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 352000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2023000,
    "deferredtaxassetscapitalizedresearchanddevelopmentamortization": 5444000,
    "deferredtaxassetsother": 10000,
    "deferredtaxassetsgross": 26316000,
    "deferredtaxassetsvaluationallowance": 26316000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.0022,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0068,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2191,
    "effectiveincometaxratereconciliationforeignresearchincentivespercent": 0.0071,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.0004,
    "effectiveincometaxratecontinuingoperations": 0.0074,
    "currentincometaxexpensebenefit": -186000,
    "operatinglosscarryforwards": 23068000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 352000,
    "taxcreditcarryforwardexpirationyear": 2041
  },
  {
    "date": "2022-12-30",
    "symbol": "PBLA",
    "period": "FY",
    "entitycentralindexkey": 1029125,
    "entityregistrantname": "Panbela Therapeutics, Inc.",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39468",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "88-2805017",
    "entityaddressaddressline1": "712 Vista Blvd, #305",
    "entityaddresscityortown": "Waconia",
    "entityaddressstateorprovince": "MN",
    "entityaddresspostalzipcode": 55387,
    "cityareacode": 952,
    "localphonenumber": "479-1196",
    "security12btitle": "Common Stock, $0.001 par value",
    "tradingsymbol": "PBLA",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entitysmallbusiness": "true",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 677,
    "auditorname": "Cherry Bekaert",
    "auditorlocation": "Tampa, Florida",
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 1049644,
    "commonstocksharesoutstanding": 1049644,
    "retainedearningsaccumulateddeficit": -91094000,
    "netincomeloss": -34933000,
    "researchanddevelopmentinprocess": 17737000,
    "netcashprovidedbyusedinoperatingactivities": -15276000,
    "cashandcashequivalentsatcarryingvalue": 1285000,
    "workingcapital": -6000000,
    "stockholdersequity": -8049000,
    "stockissuedduringperiodsharesnewissues": 502500,
    "proceedsfromissuanceofcommonstock": 93000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 2772,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 11.2,
    "proceedsfromwarrantexercises": 5000,
    "proceedsfromissuanceofcommonstocknet": 46000,
    "stockissuedduringperiodsharesexerciseofwarrantsforcash": 25,
    "cashuninsuredamount": 1000000,
    "longtermdebt": 6400000,
    "debtinstrumentinterestratestatedpercentage": 0.04,
    "interestpayablecurrentandnoncurrent": 243000,
    "debtinstrumentfaceamount": 650000,
    "licenseagreementmilestonepaymentsachievement": 90000,
    "paymentsofstockissuancecosts": 44000,
    "equityofferingcommissionpercentageofgrossproceeds": 0.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "commonstockcapitalsharesreservedforfutureissuance": 100556,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 55495,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 241.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 50511,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P0Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y1M6D",
    "allocatedsharebasedcompensationexpense": 889000,
    "incometaxesreceivable": 49000,
    "opentaxyear": "2015 2016 2017 2018 2019 2020 2021 2022",
    "proceedsfromissuanceorsaleofequitynet": 5303000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 145.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantsinperiod": 39904,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14,
    "stockissuedduringperiodsharesstockoptionsexercised": 372,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 487,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 562.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 9430,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 139.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 8184,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 135.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 487,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 562.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 269,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 67.6,
    "operatinglosscarryforwards": 23068000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 338000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "prepaidexpensecurrent": 443000,
    "assetscurrent": 1777000,
    "otherassetsnoncurrent": 3201000,
    "assets": 4978000,
    "accountspayablecurrent": 2865000,
    "accruedliabilitiescurrent": 2993000,
    "interestpayablecurrent": 325000,
    "notespayablecurrent": 650000,
    "otherlongtermdebtcurrent": 1000000,
    "liabilitiescurrent": 7833000,
    "longtermdebtnoncurrent": 5194000,
    "liabilitiesnoncurrent": 5194000,
    "liabilities": 13027000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 82285000,
    "accumulatedothercomprehensiveincomelossnetoftax": 759000,
    "liabilitiesandstockholdersequity": 4978000,
    "generalandadministrativeexpense": 6044000,
    "researchanddevelopmentexpense": 28049000,
    "operatingincomeloss": -34093000,
    "investmentincomeinterest": 14000,
    "interestexpense": 288000,
    "othernonoperatingincomeexpense": -682000,
    "nonoperatingincomeexpense": -956000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -35049000,
    "incometaxexpensebenefit": -116000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 626000,
    "comprehensiveincomenetoftax": -34307000,
    "earningspersharebasic": -67.91,
    "weightedaveragenumberofsharesoutstandingbasic": 514369,
    "sharebasedcompensation": 1088000,
    "noncashinterestexpense": 273000,
    "increasedecreaseinincometaxesreceivable": -212000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 127000,
    "paymentstoacquiredepositsinvestingactivities": 2561000,
    "increasedecreaseinaccountspayable": 2249000,
    "increasedecreaseinaccruedliabilities": 786000,
    "paymentstoacquireinprocessresearchanddevelopment": 660000,
    "cashacquiredfromacquisition": 4000,
    "netcashprovidedbyusedininvestingactivities": -656000,
    "netcashprovidedbyusedinfinancingactivities": 5354000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -4000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -10582000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 1285000,
    "interestpaidnet": 15000,
    "noncashorpartnoncashacquisitionnoncashfinancialorequityinstrumentconsiderationfairvalue": 9605000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 100556,
    "clinicaltrialrelatedliabilitiescurrent": 1760000,
    "accruedbonusescurrent": 550000,
    "accruedseverancepayandrelatedpayrolltaxcurrent": 448000,
    "accruedprofessionalfeescurrent": 147000,
    "otheraccruedliabilitiescurrent": 88000,
    "currentincometaxexpensebenefit": -116000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.108,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.13,
    "effectiveincometaxratereconciliationforeignresearchincentivespercent": 0.001,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.029,
    "effectiveincometaxratecontinuingoperations": 0.003,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 8.8,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 58.8,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 39810,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P7Y1M13D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 39810,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P7Y1M13D",
    "deferredtaxassetsoperatinglosscarryforwards": 17564000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 338000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1928000,
    "deferredtaxassetscapitalizedresearchanddevelopment": 1921000,
    "deferredtaxassetsother": 68000,
    "deferredtaxassetsgross": 21819000,
    "deferredtaxassetsvaluationallowance": 21819000,
    "sharesoutstanding": 1049644,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodvalueexerciseofwarrantsforcash": 5000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 269,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1088000,
    "stockissuedduringperiodsharesacquisitions": 182988,
    "stockissuedduringperiodvalueacquisitions": 9605000,
    "stockissuedduringperiodsharesreversestocksplits": 816,
    "adjustmentstoadditionalpaidincapitalreversestocksplit": 1000
  },
  {
    "date": "2021-12-30",
    "symbol": "PBLA",
    "period": "FY",
    "entitycentralindexkey": 1029125,
    "entityregistrantname": "Panbela Therapeutics, Inc.",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2021-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39468",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "87-0543922",
    "entityaddressaddressline1": "712 Vista Blvd, #305",
    "entityaddresscityortown": "Waconia",
    "entityaddressstateorprovince": "MN",
    "entityaddresspostalzipcode": 55387,
    "cityareacode": 952,
    "localphonenumber": "479-1196",
    "security12btitle": "Common Stock, $0.001 par value",
    "tradingsymbol": "PBLA",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entitysmallbusiness": "true",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "auditorname": "Cherry Bekaert",
    "auditorlocation": "Tampa, Florida",
    "auditorfirmid": 677,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 13443722,
    "commonstocksharesoutstanding": 13443722,
    "paymentsofstockissuancecosts": 946000,
    "retainedearningsaccumulateddeficit": -56161000,
    "netincomeloss": -10135000,
    "netcashprovidedbyusedinoperatingactivities": -6704000,
    "cashandcashequivalentsatcarryingvalue": 11867000,
    "workingcapital": 9600000,
    "stockholdersequity": 10212000,
    "stockissuedduringperiodsharesnewissues": 3333000,
    "proceedsfromissuanceofcommonstocknet": 9054000,
    "proceedsfromwarrantexercises": 1041000,
    "stockissuedduringperiodsharesexerciseofwarrantsforcash": 229000,
    "cashuninsuredamount": 11600000,
    "relatedpartytransactionpurchasesfromrelatedparty": 54600,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4.54,
    "classofwarrantorrightoutstanding": 2306516,
    "classofwarrantorrightexercisedduringperiod": 223939,
    "stockissuedduringperiodsharescashlessexerciseofwarrants": 191000,
    "classofwarrantsorrightscancelledduringtheperiod": 573339,
    "classofwarrantorrightcancelledduringperiodexerciseprice": 5,
    "stockissuedduringperiodvalueexerciseofwarrantsforcash": 1041000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "commonstockcapitalsharesreservedforfutureissuance": 2463636,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2239636,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 10790,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1345863,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P0Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 1700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y2M12D",
    "allocatedsharebasedcompensationexpense": 1083000,
    "incometaxesreceivable": 321000,
    "opentaxyear": "2015 2016 2017 2018 2019 2020 2021",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 8821,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantsinperiod": -554065,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.86,
    "stockissuedduringperiodsharesstockoptionsexercised": 4000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 0.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 219928,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 718994,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 3.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 554065,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 286157,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 3.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 2.98,
    "shareprice": 2.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0079,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 4.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 21580,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 22290,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.8,
    "operatinglosscarryforwards": 12958000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 235000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "prepaidexpensecurrent": 91000,
    "assetscurrent": 12279000,
    "otherassetsnoncurrent": 593000,
    "assets": 12872000,
    "accountspayablecurrent": 640000,
    "accruedliabilitiescurrent": 2020000,
    "liabilitiescurrent": 2660000,
    "liabilities": 2660000,
    "commonstockvalue": 13000,
    "additionalpaidincapital": 66227000,
    "accumulatedothercomprehensiveincomelossnetoftax": 133000,
    "liabilitiesandstockholdersequity": 12872000,
    "generalandadministrativeexpense": 4587000,
    "researchanddevelopmentexpense": 5423000,
    "operatingincomeloss": -10010000,
    "interestexpense": 11000,
    "othernonoperatingincomeexpense": -602000,
    "nonoperatingincomeexpense": -613000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -10623000,
    "incometaxexpensebenefit": -488000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 517000,
    "comprehensiveincomenetoftax": -9618000,
    "earningspersharebasicanddiluted": -0.87,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11709035,
    "sharebasedcompensation": 1287000,
    "increasedecreaseinincometaxesreceivable": -51000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -247000,
    "increasedecreaseinaccountspayable": 631000,
    "increasedecreaseinaccruedliabilities": 1215000,
    "paymentstoacquiredepositsinvestingactivities": 540000,
    "netcashprovidedbyusedininvestingactivities": -540000,
    "netcashprovidedbyusedinfinancingactivities": 10095000,
    "effectofexchangerateoncashandcashequivalents": -6000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 2845000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 11867000,
    "interestpaidnet": 12000,
    "sharesoutstanding": 13443000,
    "stockissuedduringperiodvaluenewissues": 3000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1287000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 22000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2463636,
    "clinicaltrialrelatedliabilitiescurrent": 992000,
    "accruedbonusescurrent": 434000,
    "accruedprofessionalfeescurrent": 235000,
    "otheraccruedliabilitiescurrent": 359000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": 0.021,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.243,
    "effectiveincometaxratereconciliationforeignresearchincentivespercent": 0.031,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.016,
    "effectiveincometaxratecontinuingoperations": 0.031,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 2.26,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 1.1,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 14000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P1Y5M12D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 15.1,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 14000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P1Y5M12D",
    "deferredtaxassetsoperatinglosscarryforwards": 9986000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 235000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1734000,
    "deferredtaxassetsother": 66000,
    "deferredtaxassetsgross": 12021000,
    "deferredtaxassetsvaluationallowance": 12021000
  },
  {
    "date": "2020-12-30",
    "symbol": "PBLA",
    "period": "FY",
    "entityregistrantname": "Panbela Therapeutics, Inc.",
    "entitycentralindexkey": 1029125,
    "tradingsymbol": "pbla",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "security12btitle": "Common Stock, $0.001 par value",
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 9664427,
    "commonstocksharesoutstanding": 9664427,
    "retainedearningsaccumulateddeficit": -46026000,
    "netincomeloss": -4768000,
    "netcashprovidedbyusedinoperatingactivities": -3854000,
    "cashandcashequivalentsatcarryingvalue": 9022000,
    "workingcapital": 8400000,
    "stockholdersequity": -384000,
    "stockissuedduringperiodsharesnewissues": 2545000,
    "proceedsfromissuanceorsaleofequitynet": 9335000,
    "proceedsfromissuanceofprivateplacement": 1746000,
    "cashuninsuredamount": 8700000,
    "stockissuedduringperiodsharesexerciseofwarrantsforcash": 43000,
    "stockissuedduringperiodvalueexerciseofwarrantsforcash": 120000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "commonstockcapitalsharesreservedforfutureissuance": 9588468,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 11500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2137499,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 33000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P146D",
    "allocatedsharebasedcompensationexpense": 7000,
    "incometaxesreceivable": 323000,
    "opentaxyear": "2015 2016 2017 2018 2019",
    "proceedsfromwarrantexercises": 120000,
    "paymentsofstockissuancecosts": 1165000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 388461,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantsinperiod": -425648,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 32360,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 600,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 2.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 501086,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 4.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 425648,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 322437,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 3.14,
    "shareprice": 9.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0039,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y273D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 11500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.45,
    "operatinglosscarryforwards": 6148000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 235000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "prepaidexpensecurrent": 412000,
    "assetscurrent": 9757000,
    "otherassetsnoncurrent": 56000,
    "assets": 9813000,
    "accountspayablecurrent": 554000,
    "accruedliabilitiescurrent": 811000,
    "liabilitiescurrent": 1365000,
    "liabilities": 1365000,
    "commonstockvalue": 10000,
    "additionalpaidincapital": 54848000,
    "accumulatedothercomprehensiveincomelossnetoftax": -384000,
    "liabilitiesandstockholdersequity": 9813000,
    "generalandadministrativeexpense": 3249000,
    "researchanddevelopmentexpense": 2505000,
    "operatingincomeloss": -5754000,
    "interestexpense": 17000,
    "incomeonforgivenessofdebt": 103000,
    "othernonoperatingincomeexpense": 605000,
    "nonoperatingincomeexpense": 691000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -5063000,
    "incometaxexpensebenefit": -295000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -689000,
    "comprehensiveincomenetoftax": -5457000,
    "earningspersharebasicanddiluted": -0.62,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 7732882,
    "sharebasedcompensation": 1205000,
    "increasedecreaseinincometaxesreceivable": 2000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -67000,
    "increasedecreaseinaccountspayable": -747000,
    "increasedecreaseinaccruedliabilities": 494000,
    "proceedsfromissuanceofunsecureddebt": 103000,
    "repaymentsofnotespayable": 743000,
    "repaymentsoflongtermdebt": 117000,
    "netcashprovidedbyusedinfinancingactivities": 10444000,
    "effectofexchangerateoncashandcashequivalents": -17000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 6573000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 9022000,
    "interestpaidnet": 8000,
    "warrantsissuedforfutureservices": 228000,
    "warrantsissuedtounderwriter": 353000,
    "amortizationofwarrantsasofferingcosts": 114000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8705467,
    "clinicaltrialrelatedliabilitiescurrent": 186000,
    "accruedbonusescurrent": 497000,
    "accruedprofessionalfeescurrent": 98000,
    "otheraccruedliabilitiescurrent": 30000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": 0.017,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.265,
    "effectiveincometaxratereconciliationforeignresearchincentivespercent": 0.054,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.038,
    "effectiveincometaxratecontinuingoperations": 0.054,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 15.1,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 10.1,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 2137499,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P7Y105D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 6.773,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 1636413,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P6Y266D",
    "sharesoutstanding": 9664000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 228000,
    "stockissuedduringperiodvaluenewissues": 9221000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1205000,
    "stockissuedduringperiodsharescashlessexerciseofwarrants": 8000,
    "deferredtaxassetsoperatinglosscarryforwards": 7660000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 235000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1498000,
    "deferredtaxassetsother": 70000,
    "deferredtaxassetsgross": 9463000,
    "deferredtaxassetsvaluationallowance": 9463000
  },
  {
    "date": "2019-12-30",
    "symbol": "PBLA",
    "period": "FY",
    "entityregistrantname": "Sun BioPharma, Inc.",
    "entitycentralindexkey": 1029125,
    "tradingsymbol": "snbp",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "security12gtitle": "Common Stock, $0.001 par value",
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 6631308,
    "commonstocksharesoutstanding": 6631308,
    "netincomeloss": -6200000,
    "netcashprovidedbyusedinoperatingactivities": -2739000,
    "cashandcashequivalentsatcarryingvalue": 2449000,
    "workingcapital": 1300000,
    "stockholdersequity": 305000,
    "stockissuedduringperiodsharesnewissues": 909000,
    "proceedsfromissuanceofprivateplacement": 3160000,
    "proceedsfromconvertibledebt": 816000,
    "intrinsicvalueofconvertibledebtwithconversionfeature": 353000,
    "debtconversionoriginaldebtamount1": 2175000,
    "repaymentsoflongtermdebt": 161000,
    "longtermdebt": 116000,
    "royaltyexpense": 10000,
    "classofwarrantorrightoutstanding": 3422099,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "commonstockcapitalsharesreservedforfutureissuance": 5186459,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1744811,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 372000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y146D",
    "allocatedsharebasedcompensationexpense": 288000,
    "incometaxesreceivable": 361000,
    "opentaxyear": "2015 2016 2017 2018 2019",
    "paymentsofdebtissuancecosts": 7000,
    "paymentsofstockissuancecosts": 16000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 314051,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 19549,
    "shareprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0225,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y182D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1030547,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantsinperiod": 733400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 733400,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 20800,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.1,
    "operatinglosscarryforwards": 3153000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 235000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "prepaidexpensecurrent": 283000,
    "assetscurrent": 3093000,
    "otherassetsnoncurrent": 51000,
    "assets": 3144000,
    "accountspayablecurrent": 597000,
    "accruedliabilitiescurrent": 304000,
    "unsecureddebtcurrent": 116000,
    "unsecuredpromissorynotepayablecurrent": 742000,
    "liabilitiescurrent": 1759000,
    "liabilities": 1759000,
    "commonstockvalue": 7000,
    "additionalpaidincapital": 42331000,
    "retainedearningsaccumulateddeficit": -41258000,
    "accumulatedothercomprehensiveincomelossnetoftax": 305000,
    "liabilitiesandstockholdersequity": 3144000,
    "generalandadministrativeexpense": 1973000,
    "researchanddevelopmentexpense": 2349000,
    "operatingincomeloss": -4322000,
    "interestexpense": 2194000,
    "othernonoperatingincomeexpense": -99000,
    "nonoperatingincomeexpense": -2293000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -6615000,
    "incometaxexpensebenefit": -415000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 22000,
    "comprehensiveincomenetoftax": -6178000,
    "earningspersharebasicanddiluted": -1.09,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 5700314,
    "sharebasedcompensation": 1093000,
    "amortizationofdebtdiscountpremium": 2066000,
    "amortizationoffinancingcosts": 12000,
    "noncashinterestexpense": 102000,
    "increasedecreaseinincometaxesreceivable": 31000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 174000,
    "increasedecreaseinaccountspayable": 301000,
    "increasedecreaseinaccruedliabilities": 92000,
    "repaymentsofnotespayable": 25000,
    "netcashprovidedbyusedinfinancingactivities": 3784000,
    "effectofexchangerateoncashandcashequivalents": -1000,
    "cashandcashequivalentsperiodincreasedecrease": 1044000,
    "interestpaidnet": 14000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 419000,
    "warrantsissuedduringperiodvalueexchangedformodificationofdebt": 14000,
    "commonstockconvertedintoconvertiblenotespayablevalue": 25000,
    "debtconversionconversionofpromissorynotesandaccruedinterestintocommonstockandwarrants": 2281000,
    "unsecuredpromissorynoteissuedinexchangeforvendoraccountspayable": 742000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5166910,
    "clinicaltrialrelatedliabilitiescurrent": 147000,
    "accruedprofessionalfeescurrent": 125000,
    "otheraccruedliabilitiescurrent": 32000,
    "debtinstrumentincreaseaccruedinterest": 103000,
    "debtconversionoriginaldebtamountofaccruedbutunpaidinterest": 105000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 397875,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 2.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 378025,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 2.41,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.059,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.324,
    "effectiveincometaxratereconciliationforeignresearchincentivespercent": 0.057,
    "effectiveincometaxratereconciliationdeferredtrueuppercent": 0.163,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.01,
    "effectiveincometaxratecontinuingoperations": 0.057,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 15.1,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 10.1,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P7Y244D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 6.526,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 1346936,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P7Y69D",
    "deferredtaxassetsoperatinglosscarryforwards": 6307000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 235000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1230000,
    "deferredtaxassetsother": 72000,
    "deferredtaxassetsgross": 7844000,
    "deferredtaxassetsvaluationallowance": 7844000,
    "sharesoutstanding": 6631000,
    "stockissuedduringperiodvaluenewissues": 3160000,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 353000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1093000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 651000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 2281000,
    "commonstockconvertedintoconvertiblenotespayableshares": 7000,
    "adjustmentstoadditionalpaidincapitalwarrantsissuedinexchangeformodificationoftermdebt": 14000
  }
]